These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29025634)

  • 1. Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study.
    Verguet S; Riumallo-Herl C; Gomez GB; Menzies NA; Houben RMGJ; Sumner T; Lalli M; White RG; Salomon JA; Cohen T; Foster N; Chatterjee S; Sweeney S; Baena IG; Lönnroth K; Weil DE; Vassall A
    Lancet Glob Health; 2017 Nov; 5(11):e1123-e1132. PubMed ID: 29025634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
    Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B
    Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of TB care and equity in distribution of catastrophic TB care costs across income quintiles in India.
    Jeyashree K; Thangaraj JWV; Shanmugasundaram D; Giridharan SLP; Pandey S; Shanmugasundaram P; Ramasamy S; Janagaraj V; Arunachalam S; Sharma R; Shah V; Bagepally BS; Chadwick J; Shewade HD; Chowdhury A; Iyer S; Rao R; Mattoo SK; Murhekar MV
    Glob Health Res Policy; 2024 Dec; 9(1):51. PubMed ID: 39648213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes as a risk factor for tuberculosis disease.
    Franco JV; Bongaerts B; Metzendorf MI; Risso A; Guo Y; Peña Silva L; Boeckmann M; Schlesinger S; Damen JA; Richter B; Baddeley A; Bastard M; Carlqvist A; Garcia-Casal MN; Hemmingsen B; Mavhunga F; Manne-Goehler J; Viney K
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD016013. PubMed ID: 39177079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of disease scenarios by state in the USA, 2022-50: a forecasting analysis for the Global Burden of Disease Study 2021.
    GBD 2021 US Burden of Disease and Forecasting Collaborators
    Lancet; 2024 Dec; 404(10469):2341-2370. PubMed ID: 39645377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
    Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF
    Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unlocking data: Decision-maker perspectives on cross-sectoral data sharing and linkage as part of a whole-systems approach to public health policy and practice.
    Tweed E; Cimova K; Craig P; Allik M; Brown D; Campbell M; Henderson D; Mayor C; Meier P; Watson N
    Public Health Res (Southampt); 2024 Nov; ():1-30. PubMed ID: 39582242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining household out of pocket payments, incidence of catastrophic expenditures and impoverishment among patients with malaria in Zambia's path towards Universal Health Coverage.
    Banda P; Masiye F; Kaonga O; Bump J; Berman P
    PLoS One; 2024; 19(12):e0312906. PubMed ID: 39656710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a systematic review and individual participant data meta-analysis.
    Roh ME; Gutman J; Murphy M; Hill J; Madanitsa M; Kakuru A; Barsosio HC; Kariuki S; Lusingu JPA; Mosha F; Kajubi R; Kamya MR; Mathanga D; Chinkhumba J; Laufer MK; Mlugu E; Kamuhabwa AAR; Aklillu E; Minzi O; Okoro RN; Geidam AD; Ohieku JD; Desai M; Jagannathan P; Dorsey G; Ter Kuile FO
    medRxiv; 2024 Nov; ():. PubMed ID: 39649586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethical and economic implications of the adoption of novel plant-based beef substitutes in the USA: a general equilibrium modelling study.
    Mason-D'Croz D; Barnhill A; Bernstein J; Bogard J; Dennis G; Dixon P; Fanzo J; Herrero M; McLaren R; Palmer J; Rieder T; Rimmer M; Faden R
    Lancet Planet Health; 2022 Aug; 6(8):e658-e669. PubMed ID: 35932786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of abstinence-based and harm reduction-based interventions in reducing problematic substance use in adults who are experiencing homelessness in high income countries: A systematic review and meta-analysis: A systematic review.
    O'Leary C; Ralphs R; Stevenson J; Smith A; Harrison J; Kiss Z; Armitage H
    Campbell Syst Rev; 2024 Jun; 20(2):e1396. PubMed ID: 38645303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results.
    Wing K; Williamson E; Carpenter JR; Wise L; Schneeweiss S; Smeeth L; Quint JK; Douglas I
    Health Technol Assess; 2021 Aug; 25(51):1-70. PubMed ID: 34463610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study.
    Smith J; Bansi-Matharu L; Cambiano V; Dimitrov D; Bershteyn A; van de Vijver D; Kripke K; Revill P; Boily MC; Meyer-Rath G; Taramusi I; Lundgren JD; van Oosterhout JJ; Kuritzkes D; Schaefer R; Siedner MJ; Schapiro J; Delany-Moretlwe S; Landovitz RJ; Flexner C; Jordan M; Venter F; Radebe M; Ripin D; Jenkins S; Resar D; Amole C; Shahmanesh M; Gupta RK; Raizes E; Johnson C; Inzaule S; Shafer R; Warren M; Stansfield S; Paredes R; Phillips AN;
    Lancet HIV; 2023 Apr; 10(4):e254-e265. PubMed ID: 36642087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare workers' informal uses of mobile phones and other mobile devices to support their work: a qualitative evidence synthesis.
    Glenton C; Paulsen E; Agarwal S; Gopinathan U; Johansen M; Kyaddondo D; Munabi-Babigumira S; Nabukenya J; Nakityo I; Namaganda R; Namitala J; Neumark T; Nsangi A; Pakenham-Walsh NM; Rashidian A; Royston G; Sewankambo N; Tamrat T; Lewin S
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD015705. PubMed ID: 39189465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global, regional, and national burden of HIV/AIDS, 1990-2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021.
    GBD 2021 HIV Collaborators
    Lancet HIV; 2024 Dec; 11(12):e807-e822. PubMed ID: 39608393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Undernutrition as a risk factor for tuberculosis disease.
    Franco JV; Bongaerts B; Metzendorf MI; Risso A; Guo Y; Peña Silva L; Boeckmann M; Schlesinger S; Damen JA; Richter B; Baddeley A; Bastard M; Carlqvist A; Garcia-Casal MN; Hemmingsen B; Mavhunga F; Manne-Goehler J; Viney K
    Cochrane Database Syst Rev; 2024 Jun; 6(6):CD015890. PubMed ID: 38860538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genedrive kit for detecting single nucleotide polymorphism m.1555A>G in neonates and their mothers: a systematic review and cost-effectiveness analysis.
    Shabaninejad H; Kenny RP; Robinson T; Stoniute A; O'Keefe H; Still M; Thornton C; Pearson F; Beyer F; Meader N
    Health Technol Assess; 2024 Oct; 28(75):1-75. PubMed ID: 39487741
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.